Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 110 of the 115 references it cites were found in a registry or an index; 22 of the 65 sources its claims cite were checked for support.
Abstract
Insulin resistance is a characteristic feature of type 2 diabetes and plays a major role in the pathogenesis of the disease (1,2). Although �-cell failure is the sine qua non for development of type 2 diabetes, skeletal muscle insulin resistance is considered to be the initiating or primary defect that is evident decades before �-cell failure and overt hyperglycemia develops (3,4). Insulin resistance is defined as a reduced response of target tissues (compared with subjects with normal glucose tolerance [NGT] without a family history of diabetes), such as the skeletal muscle, liver, and adipocytes, to
Overview
CoChat Summary
TL;DR
This review argues that skeletal muscle insulin resistance—especially impaired glycogen synthesis—is the initiating/primary defect in most type 2 diabetes, preceding β-cell failure and overt hyperglycemia. It concludes that overt diabetes requires β-cell failure to supervene, while muscle insulin resistance is already evident in normal glucose-tolerant high-risk relatives and prospective populations.
Key findings
- Skeletal muscle is the predominant site of insulin-mediated postprandial glucose uptake: under euglycemic hyperinsulinemia, ∼80% of glucose uptake occurs in skeletal muscle; leg muscle glucose uptake plateaus at ∼10 mg/kg leg weight per minute after 60 min, and in lean type 2 diabetic subjects it is reduced by ∼50% during the last hour of the insulin clamp.
- In lean NGT offspring of two type 2 diabetic parents, a two-step euglycemic clamp (20 and 40 mU/m² per min; plasma insulin ∼40 and ∼80 μU/ml) showed glucose uptake decreased by 33% and 43%, respectively; the impairment was accounted for entirely by reduced nonoxidative glucose metabolism/glycogen synthesis, with no defect in insulin suppression of hepatic glucose production.
- Prospective Pima Indian data showed both progressors and nonprogressors had a further 11–14% reduction in insulin sensitivity; nonprogressors increased insulin secretion by 30%, whereas progression to type 2 diabetes was associated with a 78% decline in the acute insulin response to intravenous glucose.
- Hyperinsulinemia itself worsens muscle insulin resistance: a 72 pmol/l (11 μU/ml) increase in plasma insulin for 72–96 h reduced insulin-stimulated glucose disposal by 30–40%, entirely via impaired nonoxidative glucose disposal; in rats, 7-day hyperinsulinemia reduced total-body glucose uptake, storage, and glycolysis by 39%, 62%, and 26%. Mitochondrial ATP production increased by 90% in NGT subjects without family history but only 5% in insulin-resistant offspring.
Methods
- Narrative review/symposium article; no primary study design or new sample. It synthesizes human studies using the euglycemic insulin clamp (described as the gold standard), indirect calorimetry, muscle biopsy, femoral/forearm catheterization, PET, NMR spectroscopy, OGTT, and prospective follow-up.
- Populations discussed include lean NGT first-degree relatives/offspring of two type 2 diabetic parents, Mexican Americans, Pima Indians, Caucasians in San Antonio, and type 2 diabetic subjects. Main analysis is qualitative synthesis of cited evidence.
Limitations
- Stated: by the time hyperglycemia is manifest, multiple abnormalities (elevated glucose, FFA, and cytokines) coexist, making it extremely difficult to separate each defect’s contribution; at initial presentation it is not possible to define which defect came first.
- Stated: it is unclear whether mitochondrial dysfunction leads to increased intramyocellular lipid and insulin resistance or increased muscle lipid leads to mitochondrial dysfunction and insulin resistance (“which is the cart and which is the horse”).
- Evident: as a narrative review, it lacks systematic search, formal quality assessment, or meta-analysis; conclusions depend on selected cited studies, and several figures are in an online appendix rather than the text.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
14 Valid · 1 Not valid · 22 Not checked · 11 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In type 2 diabetes, impaired glycogen synthesis secondary to reduced glycogen synthase activity is the earliest detectable metabolic defect ( 39 – 41 ).”
What the sources say
- Not matchedcites [39] DeFronzo, 1997, Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying genes, Diabetes Rev
We searched by its title and found no matching paper.
- Partly supportedcites [40] Bogardus, 1984, Correlation between muscle glycogen synthase activity and in vivo insulin action in man, J Clin Invest sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) reports a correlation between muscle glycogen synthase activity and insulin-mediated glucose storage in glucose-tolerant and diabetic subjects. It hypothesizes a link between reduced enzyme activity and impaired glucose handling, but does not establish that one causes the other or that impaired glycogen synthesis is the earliest detectable metabolic defect in type 2 diabetes. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [41] Shulman, 1990, Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy, N Engl J Med source
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Not matched
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Maintaining the integrity of the IRS-1/PI-3 kinase/Akt pathway is essential for normal insulin-mediated glucose uptake in skeletal muscle ( 26 ).”
What the sources say
- Partly supportedcites [26] Krook, 2000, Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients, Diabetes sourceExperimental — accuracy not yet measured
The paper’s introduction identifies IRS-1 and PI 3-kinase as components of insulin signaling involved in skeletal-muscle glucose transport. Its study summary says reduced PI 3-kinase activity may partly account for reduced insulin-stimulated glucose transport, while additional defects contribute. The cited passages do not establish a role for Akt or show that integrity of the entire pathway is essential for normal uptake. (LLM, conf=0.88)
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Multiple investigators unequivocally have demonstrated that lean NGT offspring of two parents with type 2 diabetes exhibit moderate to severe skeletal muscle insulin resistance ( 28 – 33 ).”
What the sources say
- Not checked — no full text of the sourcecites [28] Perseghin, 1997, Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study, Diabetes source
- Not checked — no full text of the sourcecites [29] Ferrannini, 2003, Influence of ethnicity and familial diabetes on glucose tolerance and insulin action: a physiological analysis, J Clin Endocrinol Metab source
- Not checked — no full text of the sourcecites [30] Kashyap, 2004, Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetes, Am J Physiol Endocrinol Metab source
- Partly supportedcites [31] Vaag, 1992, Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus, J Clin Invest sourceExperimental — accuracy not yet measured
The Subjects section says the participants were nonobese, had normal oral glucose tolerance, and had at least one parent with NIDDM—not necessarily two. The Discussion reports skeletal-muscle insulin resistance but also considerable overlap with controls; it does not establish moderate-to-severe resistance in offspring of two affected parents. Page numbers are unavailable in our copy. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [32] Gulli, 1992, The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents, Diabetes source
- Not checked — no full text of the sourcecites [33] Tripathy, 2003, Familiality of metabolic abnormalities is dependent on age at onset and phenotype of the type 2 diabetic proband, Am J Physiol source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“In lean insulin-resistant NGT offspring of type 2 diabetic parents, increased serine phosphorylation of IRS-1 in skeletal muscle has been documented in association with impaired activation of Akt ( 57 ) (Fig. A11).”
What the sources say
- Supportedcites [57] Morino, 2005, Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents, J Clin Invest source
The Introduction describes the offspring as young, lean, normoglycemic, and insulin-resistant. The Results report increased IRS-1 serine phosphorylation and reduced insulin-stimulated Akt phosphorylation in the offspring, and the Discussion explicitly describes these findings as associated. Page numbers are not provided in our copy. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This observation is of important clinical significance, since diacylglycerol, long-chain fatty acyl CoAs, and ceramides all have been shown to cause serine phosphorylation of insulin resistance and IRS-1 and lead to the development of insulin resistance in skeletal muscle ( 59 , 60 ).”
What the sources say
- Not checked — no full text of the sourcecites [59] Hotamisligil, 1996, IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance, Science source
- Partly supportedcites [60] Jiang, 1999, Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats, J Clin Invest sourceExperimental — accuracy not yet measured
The Discussion says elevated free fatty acids may impair insulin’s metabolic action and notes protein kinase C activation in skeletal muscle. It does not say that diacylglycerol, long-chain fatty acyl CoAs, or ceramides cause IRS-1 serine phosphorylation and thereby produce skeletal-muscle insulin resistance; its serine-phosphorylation discussion concerns the insulin receptor instead. Page numbers are unavailable in our copy. (LLM, conf=0.83)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
21 more claims · 6 with their cited sources checked
Create a free account to see all 48 claims and to verify the 1 reference still open.
- Probably not a substantial claim. 4
- It may state two separate claims as one. 20
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Various epidemiological and experimental studies have shown that muscle weakness, decreased muscle mass, reduced activation of glycogen synthase, and alterations in the numbers of glycolytic skeletal muscle fibers are related to, and may precede, insulin resistance, glucose intolerance, and T2D [332,333].”
From Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR) (2025) · cites this paper as [333]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Even though pancreatic beta cell dysfunction is the main pathogenesis of type 2 diabetes mellitus, given that the uptake of postprandial glucose by skeletal muscles is approximately 80–90%, skeletal muscle IR plays a crucial role in the development and progression of diabetes mellitus [129,130].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [130]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Dysregulation of these processes contributes to the pathogenesis of numerous diseases, including diabetes and obesity (DeFronzo and Tripathy, 2009; Sugden et al., 2009), mitochondrial disorders (Kerr, 2013), cardiac failure (Fillmore and Lopaschuk, 2013), neurodegenerative disorders (Cunnane et al., 2011; Yao et al., 2011), and cancer (Currie et al., 2013; Tennant et al., 2010).”
From Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier (2014) · cites this paper as DeFronzo and Tripathy, 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, the SM accounts for >80% of glucose uptake in the post-prandial period following an oral glucose load, with linear increases in uptake over time [17,20].”
From Optimised Skeletal Muscle Mass as a Key Strategy for Obesity Management (2025) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Skeletal muscle is the main tissue responsible for insulin-stimulated glucose disposal and an impaired uptake is common in obesity and has substantial impact on whole-body glucose turnover.8,9”
From Changes in lean body mass with glucagon‐like peptide ‐1‐based therapies and mitigation strategies (2024) · cites this paper as [8]
Experimental — accuracy not yet measured
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425 · cited 1×
“RESEARCH DESIGN AND METHODS — The euglycemic insulin clamp technique (5) is considered to be the gold standard for measuring insulin action in vivo.”
BackgroundSelf-citationMatsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621 · cited 1×
“70) with insulin sensitivity measured with the euglycemic insulin clamp (9).”
MethodSelf-citationKatz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
Critical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760 · cited 1×
“This results in activation of downstream protein kinase B (also called Akt) and phosphorylation of Akt substrate 160 (AS160), which facilitates the translocation of GLUT4 to the sarcolemma and subsequent entry of glucose into the cell (25).”
BackgroundHotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456 · cited 7×
“Because the majority of type 2 diabetic subjects are obese, they also have daylong elevation of the plasma free fatty acid (FFA) concentration and increased circulating levels of inflammatory cytokines (1,2).”
BackgroundInfluentialSelf-citation
Research works printed but not linked: 2
- Pendergrass, 2007, Muscle glucose transport and phosphorylation in type 2 diabetic, obese nondiabetic, and genetically predisposed individuals, Am J Physiol Endocrinol Metab, 292, E92, 10.1152/ajpendo.00617.2005 · DOI · Paper page
- Morino, 2005, Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents, J Clin Invest, 115, 3587, 10.1172/jci25151 · DOI · Paper page
Cited by
Items 1,101–1,200 of 2,099
Shin, Y., Moon, J. H., Oh, T. J., Ahn, C. H., Moon, J. H., Choi, S. H., & Jang, H. C. (2022) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0334 · Cited by 11
“Since skeletal muscle is a metabolically active organ that accounts for approximately 30% of the resting metabolic rate, reduced skeletal muscle mass can impair glucose utilization and decrease reservoir capacity [16,17].”
Zhou, J., Bai, L., Tong, L., Jia, L., & Ding, W. (2022) · Scientific Reports · doi:10.1038/s41598-022-15012-0 · Cited by 11
Giannini, C., Polidori, N., Chiarelli, F., & Mohn, A. (2022) · International Journal of Obesity · doi:10.1038/s41366-022-01164-6 · Cited by 12
Xu, P., Wang, M., Sharma, N., Comeau, M. E., Wabitsch, M., Langefeld, C. D., Civelek, M., Zhang, B., & Das, S. K. (2023) · Cell Systems · doi:10.1016/j.cels.2022.12.005 · Cited by 11
Wohlers, L. M., Powers, B. L., Chin, E. R., & Spangenburg, E. E. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00617.2012 · Cited by 12
Hinton, P. S. (2016) · Medical Hypotheses · doi:10.1016/j.mehy.2016.05.008 · Cited by 14
Dysfunction of SERCA pumps as novel mechanism of methylglyoxal cytotoxicity
Žižková, P., Viskupičová, J., Heger, V., Račková, L., Májeková, M., & Horáková, Ľ. (2018) · Cell Calcium · doi:10.1016/j.ceca.2018.06.003 · Cited by 11
Lima‐Cabello, E., Morales, S., León, J., Alché, V., Clemente, A., Ramírez, J. D. D. A., & Jiménez-López, J. C. (2018) · Food & Function · doi:10.1039/c8fo01164h · Cited by 16
Jall, S., Angelis, M. D., Lundsgaard, A., Fritzen, A. M., Nicolaisen, T. S., Klein, A. B., Novikoff, A., Sachs, S., Richter, E. A., Kiens, B., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05117-4 · Cited by 14
“DMPP has no effect on Akt signalling, but increases glycogen content in skeletal muscle Given the quantitative importance of skeletal muscle in whole-body postprandial glucose disposal [19, 20], we investigated canonical insulin signalling in in vivo glucose-stimulated quadriceps muscle after 8 days of daily DMPP trea…”
BackgroundmiR-378a-3p Participates in Metformin’s Mechanism of Action on C2C12 Cells under Hyperglycemia
Machado, I. F., Teodoro, J. S., Castela, A. C., Palmeira, C. M., & Rolo, A. P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020541 · Cited by 12
Pandey, J., Dev, K., Chattopadhyay, S., Kadan, S., Sharma, T., Maurya, R., Sanyal, S., Siddiqi, M. I., Zaid, H., & Tamrakar, A. K. (2021) · Molecules · doi:10.3390/molecules26113129 · Cited by 11
“Skeletal muscle, being the major insulin-targeted tissue, is responsible for maintenance of whole body glucose homeostasis and contributing to the almost 80% of the glucose utilization [36].”
BackgroundMestareehi, A., Zhang, X., Seyoum, B., Msallaty, Z., Mallisho, A., Burghardt, K. J., Kowluru, A., & Yi, Z. (2021) · Journal of Diabetes Research · doi:10.1155/2021/9979234 · Cited by 15
Sanni, A. A., Blanks, A. M., Derella, C. C., Horsager, C., Crandall, R. H., Looney, J. C., Sanchez, S., Norland, K., Ye, B., Thomas, J., et al. (2022) · Physiological Reports · doi:10.14814/phy2.15208 · Cited by 10
Modeling Energy Dynamics in Mice with Skeletal Muscle Hypertrophy Fed High Calorie Diets
Bond, N. D., Guo, J., Hall, K. D., & McPherron, A. C. (2016) · International Journal of Biological Sciences · doi:10.7150/ijbs.13525 · Cited by 11
“Insulin resistance, a prerequisite for the development of T2DM, is detected earlier in skeletal muscle than in other tissues (2).”
BackgroundBurgos, S. A., Chandurkar, V., Tsoukas, M. A., Chevalier, S., Morais, J. A., Lamarche, M., & Marliss, E. B. (2016) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000312 · Cited by 13
“Elevated KIC concentration is also part of the metabolomic signature of T2D.”
BackgroundInfluentialGestational retinal microvasculature and the risk of 5 year postpartum abnormal glucose metabolism
Li, L., Tan, K. H., Aris, I. M., Chong, Y. S., Saw, S., Gluckman, P. D., Wang, J. J., & Wong, T. Y. (2017) · Diabetologia · doi:10.1007/s00125-017-4441-x · Cited by 11
“Our results in pregnant women are not only in keeping with previous findings in the general population [18] but also support the following speculations that may have implications in future research: (1) retinal venular widening is suggested to reflect degrees of endothelial dysfunction and inflammation [18]; (2) retin…”
ResultResetting Time: The Role of Exercise Timing in Circadian Reprogramming for Metabolic Health
Hesketh, S. J. (2025) · Obesities · doi:10.3390/obesities5030059 · Cited by 15
“Skeletal muscle comprises almost 40% of body mass in healthy adults and is a primary site for glucose disposal, fatty acid oxidation, and circadian entrainment [6,22], positioning it as an important tissue for metabolic regulation.”
Knudsen, J. R., Madsen, A. B., Li, Z., Andersen, N. R., Schjerling, P., & Jensen, T. E. (2022) · Physiological Reports · doi:10.14814/phy2.15183 · Cited by 10
“Skeletal muscle is quantitatively the largest site of post- prandial insulin- stimulated glucose disposal and a major site of insulin- resistance (DeFronzo & Tripathy, 2009).”
Backgroundde Celis, M. F. R., & Bonner‐Weir, S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1217729 · Cited by 13
“Another tissue that shows an impaired response to insulin signaling in scenarios of insulin resistance and diabetes is muscle (57, 58).”
BackgroundPiras, A., & Raffi, M. (2023) · doi:10.20944/preprints202309.0363.v1 · Cited by 10
“Considering that 80% of insulin-mediated glucose uptake occurs in skeletal muscle (lean mass) [60], we should consider the importance of increasing lean mass for improving glycemic control in these individuals [61].”
BackgroundIntramuscular diacylglycerol accumulates with acute hyperinsulinemia in insulin-resistant phenotypes
McKenna, C. F., Stierwalt, H. D., Berry, K. A. Z., Ehrlicher, S. E., Robinson, M. M., Zarini, S., KAHN, D. E., Snell‐Bergeon, J. K., Perreault, L., Bergman, B. C., et al. (2024) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00368.2023 · Cited by 11
Hoekstra, S. P., King, J. A., Fenton, J., Kirk, N., Willis, S. A., Phillips, S. M., Webborn, N., Tolfrey, K., den Bosch, J. D. V., & Goosey-Tolfrey, V. L. (2024) · Physiological Reports · doi:10.14814/phy2.70073 · Cited by 13
“…study, both NMES and NMES-RT led to improved insulin sensitivity in the fasted state, as indicated by a lower circulating insulin concentration for the same or lower glucose concentration and a lower HOMA-IR, which likely reflects improved hepatic insulin sensitivity (DeFronzo & Tripathy, 2009).”
BackgroundZhu, H., Fu, Q., Chen, R., Luo, L., Yu, M., & Zhou, Y. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1483045 · Cited by 12
“It is likely that because decanoic acid plays a crucial role in alleviating insulin resistance (IR) and inflammatory response, which are key factors in the onset and progress of diabetes (18, 40).”
Skeletal muscle disorders as risk factors for type 2 diabetes
Tammineni, E. R., Manno, C. D., Oza, G., & Figueroa, L. (2025) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2025.112466 · Cited by 13
Guo, Y., Xu, N., Meng, Q., Zhong, M., Yang, M., Xu, F., Zhang, L., Jiang, M., Wu, J., Ma, Z., et al. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119938 · Cited by 13
Molecular physiopathology of obesity-related diseases: multi-organ integration by GRK2
Lucas, E., Cruces‐Sande, M., Briones, A. M., Salaíces, M., Mayor, F., Murga, C., & Vila‐Bedmar, R. (2015) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2015.1107589 · Cited by 14
“Several studies of this inflammatory process underlying the IR and metabolic dysfunction that precedes T2D, have identified components of both the innate and adaptive immune response as key players in regulating metabolic homeostasis (reviewed in Brestoff & Artis (2015)).”
BackgroundInfluentialInfluence of physical inactivity on arterial compliance during a glucose challenge
Credeur, D. P., Reynolds, L. J., Holwerda, S. W., Vranish, J. R., Young, B. E., Wang, J., Thyfault, J. P., & Fadel, P. J. (2018) · Experimental Physiology · doi:10.1113/ep086713 · Cited by 10
McKee, A. M., & Morley, J. E. (2019) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2019.06.006 · Cited by 14
Effects of protein supplementation on muscle wasting disorders: A brief update of the evidence
Kirk, B., Iuliano, S., Daly, R. M., & Duque, G. (2020) · Australian Journal on Ageing · doi:10.1111/ajag.12853 · Cited by 9
Mansuri, M. L., Sharma, G., Parihar, P., Dube, K. T., Sharma, T., Parihar, A., & Parihar, M. S. (2021) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22744 · Cited by 11
Huang, W., Liao, K., Hsieh, S., Pan, P., Kuan, Y., Liao, S., Chen, C., & Chen, W. (2021) · Environmental Toxicology · doi:10.1002/tox.23313 · Cited by 11
“The skeletal muscles are the major tissues of disposal of ingested glucose.(45) In aging or diet-induced obese mice and rats, supplementation with MLB ameliorated insulin resistance and decreased Akt signaling.”
BackgroundKotikalapudi, N., Sampath, S. J. P., Sinha, S. N., Bhonde, R. R., Mungamuri, S. K., & Venkatesan, V. (2022) · Human Cell · doi:10.1007/s13577-021-00664-3 · Cited by 11
“During T2D, there is a high glucose accumulation in the peripheral blood due to dysregulation of insulin signaling in the skeletal muscle [50], which accounts for nearly 70% of insulin-dependent glucose disposal [51].”
BackgroundChaves, A., Zheng, D., Johnson, J. A., Bergman, B. C., Patinkin, Z. W., Zaegel, V., Biagioni, E. M., Krassovskaia, P. M., Broskey, N. T., May, L. E., et al. (2022) · Diabetes · doi:10.2337/db21-0812 · Cited by 10
“One underlying factor in the pathogenesis of these diseases is impaired insulin action in skeletal muscle and adipose tissues, which contributes to systemic insulin resistance (7).”
BackgroundAyan, E. B., & DeMirci, H. (2022) · Current Diabetes Reviews · doi:10.2174/1573399819666220610150342 · Cited by 15
Distribution of lean mass and mortality risk in patients with type 2 diabetes
Ding, L., Fan, Y., Qiao, J., He, J., Wang, R., He, Q., Cui, J., Ma, Z., Zheng, F., Gao, H., et al. (2022) · Primary care diabetes · doi:10.1016/j.pcd.2022.09.003 · Cited by 11
Binwal, M., Babu, V., Israr, K. M., Kashyap, P. K., Maurya, A. K., Padalia, R. C., Tandon, S., & Bawankule, D. U. (2023) · Inflammopharmacology · doi:10.1007/s10787-022-01119-3 · Cited by 10
Cutler, H. B., Madsen, S., Masson, S. W. C., Cooke, K. C., Potter, M., Burchfield, J. G., Stöckli, J., Nelson, M. E., Cooney, G. J., & James, D. E. (2023) · Diabetes · doi:10.2337/db23-0035 · Cited by 10
The Neuropeptide Galanin Benefits Insulin Sensitivity in Subjects with Type 2 Diabetes
Fang, P., Yu, M., Shi, M., He, B., Zhang, Z., & Bo, P. (2013) · Current Protein and Peptide Science · doi:10.2174/1389203711209070611 · Cited by 10
Naidoo, P., & Islam, M. S. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2014.02.019 · Cited by 11
Badin, P.-M., Sopariwala, D. H., Lorca, S., & Narkar, V. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168457 · Cited by 10
Peck, B. D., Huot, J. R., Renzi, T., Arthur, S. T., Turner, M. J., & Marino, J. S. (2017) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00521.2016 · Cited by 12
Atherothrombosis is a Thrombotic, not Inflammatory Disease
Sloop, G. D., Weidman, J. J., & Cyr, J. A. S. (2017) · Cureus · doi:10.7759/cureus.1909 · Cited by 14
Surapongchai, J., Rattanavichit, Y., Buniam, J., & Saengsirisuwan, V. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00358 · Cited by 10
“Together, these multifaceted conditions are known as insulin resistance syndrome, a major risk factor of diabetes and cardiovascular diseases (Reaven, 2005; DeFronzo and Tripathy, 2009).”
BackgroundArsenic Exposure and Lifestyle-Related Diseases
Xu, Y., Fu, J., Wang, H. H., Hou, Y., & Pi, J. (2018) · Current topics in environmental health and preventive medicine · doi:10.1007/978-981-13-2565-6_6 · Cited by 13
Sarcopenia and diabetes mellitus: evidence for a bi-directional relationship
Mesinovic, J., & Scott, D. S. (2019) · European Geriatric Medicine · doi:10.1007/s41999-019-00230-z · Cited by 13
Reducing 14-3-3ζ expression influences adipocyte maturity and impairs function
Oppong, A. K., Diallo, K., Frayne, I. R., Rosiers, C. D., & Lim, G. E. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00093.2020 · Cited by 10
Shah, M., Stolbov, L. A., Yakovleva, T. A., Tang, W., Sokolov, V., Penland, R. C., Boulton, D. W., & PARKINSON, J. R. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14305 · Cited by 13
“stand dapagliflozinʼs effect on the glucose-insulin dynamic system in patients with T2DM for whom feedback control between glucose and insulin is impaired owing to muscular and hepatic insulin resistance.(4,5) The aim of the present study was to use computational modelling to investigate the interplay of dapagliflozin…”
BackgroundFree Fatty Acid Impairs Myogenic Differentiation through the AMPK α -MicroRNA 206 Pathway
Jiang, A., Guo, H., Zhang, L., Jiang, X., Zhang, X., Wu, W., & Liu, H. (2021) · Molecular and Cellular Biology · doi:10.1128/mcb.00327-21 · Cited by 10
“amyotrophic lateral sclerosis (ALS), and type 2 diabetes (5, 9, 10).”
BackgroundAzad, M. H., Niktab, I., Dastjerdi, S., Abedpoor, N., Rahimi, G., Safaeinejad, Z., Peymani, M., Forootan, F. S., Asadi‐Shekaari, M., Nasr‐Esfahani, M. H., et al. (2022) · Nutrition & Metabolism · doi:10.1186/s12986-022-00652-w · Cited by 13
“It is characterized by hyperglycemia, due to the development of insulin resistance (IR) in the peripheral tissues [1].”
BackgroundRoot Cause for Metabolic Syndrome and Type 2 Diabetes
Baskin, R. G., & Alfakara, D. (2022) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2022.10.007 · Cited by 15
Banack, H. R., LaMonte, M. J., Manson, J. E., Zhu, K., Evans, W. J., Shankaran, M., & Wactawski‐Wende, J. (2022) · PLoS ONE · doi:10.1371/journal.pone.0278723 · Cited by 13
“In the presence of insulin resistance, activation of the mTOR pathway is inhibited and autophagy is activated [16, 32, 33].”
BackgroundInfluentialInvolvement of mTOR in Type 2 CRF Receptor Inhibition of Insulin Signaling in Muscle Cells
Chao, H., Li, H., Grande, R. C., Lira, V. A., Yan, Z., Harris, T. E., & Li, C. (2015) · Molecular Endocrinology · doi:10.1210/me.2014-1245 · Cited by 10
Altuve, M., Severeyn, É., & Wong, S. (2015) · Symposium on Signal Processing, Images and Computer Vision (STSIVA) · doi:10.1109/stsiva.2015.7330444 · Cited by 13
“It is well known from previous studies that when baseline blood glucose and insulin levels are altered, therefore detectable with the HOMA–IR index, is because the subject already has insulin alterations [25, 8].”
BackgroundKarimian, J., Khazaei, M., & Shekarchizadeh, P. (2015) · Asian Journal of Sports Medicine · doi:10.5812/asjsm.24040 · Cited by 12
“They were divided into four groups: (1) control; (2) diabetic; (3) diabetic trained and (4) control trained (n = 9 each).”
BackgroundJo, A., Jung, J., Kim, E., & Park, S. B. (2016) · Chemical Communications · doi:10.1039/c6cc02587k · Cited by 10
Sové, R. J., Goldman, D., & Fraser, G. M. (2016) · Microcirculation · doi:10.1111/micc.12342 · Cited by 10
Antinozzi, C., Marampon, F., Sgrò, P., Tombolini, V., Lenzi, A., Crescioli, C., & Luigi, L. D. (2019) · Journal of Endocrinological Investigation · doi:10.1007/s40618-018-0998-6 · Cited by 10
Kuo, K.-T., Chang, Y., Wu, I.-H., Lu, F.-H., Yang, Y., Wu, J., & Chang, C. (2019) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2019.05.004 · Cited by 12
Salau, V. F., Erukainure, O. L., Bharuth, V., Ibeji, C. U., Olasehinde, T. A., & Islam, M. S. (2020) · Neuroscience Research · doi:10.1016/j.neures.2020.06.008 · Cited by 9
Lee, E. H., & Neppl, R. L. (2021) · Genes · doi:10.3390/genes12050688 · Cited by 13
“Although insulin resistance in skeletal muscle is the primary defect in type 2 diabetes [315], and dysregulation of INSR splicing occurs in the insulin target tissues of patients with insulin resistance [312,313], the role of INSR splicing in the pathogenesis of type 2 diabetes is unclear [303].”
BackgroundHigh-fat diet and palmitate inhibits FNDC5 expression via AMPK-Zfp57 pathway in mouse muscle cells
Guo, Q., Zhang, B., Du, H., Zhu, R., Sun, X., Fan, X., Wei, X., Yang, D., Oh, Y., Fan, L., et al. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.110265 · Cited by 12
Li, J., Zhang, Z., Zhang, C., Zhu, Q., Zhao, J., Zong, H., Deng, Q., Zheng, J., Wu, E., Wu, R., et al. (2023) · JMIR Public Health and Surveillance · doi:10.2196/49652 · Cited by 10
Garneau, L., Mulvihill, E. E., Smith, S. R., Sparks, L. M., & Aguer, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094889 · Cited by 15
“In patients with T2D, some of the earliest metabolic manifestations of the disease are the development of skeletal muscle insulin resistance and mitochondrial dysfunction [4,5].”
BackgroundAydin, B. N., Stinson, E. J., Hanson, R. L., Looker, H. C., de Baca, T. C., Krakoff, J. A., & Chang, D. C. (2024) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000763 · Cited by 10
“Prior evidence indicates that muscle, which is found in larger amounts in the body, is more important than liver in determining glucose concentrations (40).”
Chen, Y., Liao, J., Zeng, Y., Ma, H., Jiang, C., Yu, S., Wang, X., & Zhong, Q. (2024) · European Geriatric Medicine · doi:10.1007/s41999-024-01039-1 · Cited by 11
“Second, skeletal muscle plays a crucial role in glucose homeostasis and carbohydrate metabolism, which can impact blood glucose levels, leading to the development and progression of DM [32].”
The Physical Activity Paradox in Low Muscle Mass in Middle-Aged and Older Adults
Kim, B., Osuka, Y., Okubo, Y., Zhao, X., Kim, G.-M., & Oh, S. (2024) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2024.10.015 · Cited by 10
Xiao, Y., Fan, Y., & Feng, Z. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1485807 · Cited by 13
Ye, C., Chen, G., Huang, W., & Liu, Y. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.12.041 · Cited by 11
Associations between skeletal muscle strength and chronic kidney disease in patients with MASLD
Zhang, X.-L., Gu, Y., Zhao, J., Zhu, P., Chen, W., Li, G., Liu, W., Zheng, W., Zhang, N., Chen, L., et al. (2025) · Communications Medicine · doi:10.1038/s43856-025-00821-x · Cited by 11
Kim, J. H., Lee, S., Jang, H. N., Jung, S., Jung, M. H., Yun, J. W., Jeon, H., Kim, H., Chang, S., Lee, E. J., et al. (2025) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13810 · Cited by 12
“Notably, skeletal muscle insulin resistance plays a critical role in the pathogenesis of T2DM [29].”
Delay in ATP-dependent calcium inflow may affect insulin secretion from pancreatic beta-cell
Das, P. N., Halder, S., Bairagi, N., & Chatterjee, S. (2020) · Applied Mathematical Modelling · doi:10.1016/j.apm.2020.03.030 · Cited by 10
Johanns, M., Corbet, C., Jacobs, R., Drappier, M., Bommer, G. T., Herinckx, G., Vertommen, D., Tajeddine, N., Young, D., Messens, J., et al. (2022) · Biochemical Journal · doi:10.1042/bcj20220170 · Cited by 9
Shen, C., Elmassry, M. M., Grue, K. A., Joiner, H. E., Jacobo, A. U., Hamood, A. N., & Chung, E. (2022) · Metabolites · doi:10.3390/metabo12100913 · Cited by 9
Lu, X., Yue, J., Liu, Q., He, S., Dong, Y., Zhang, M., Qi, Y., Yang, M., Zhang, W., Xu, H., et al. (2023) · Endocrine Connections · doi:10.1530/ec-23-0248 · Cited by 12
“It is responsible for the majority of glucose uptake in the postprandial state and is also considered as the primary driver of systemic insulin resistance (6, 7).”
DOCK3 regulates normal skeletal muscle regeneration and glucose metabolism
Samani, A., Karuppasamy, M., English, K. G., Siler, C. A., Wang, Y., Widrick, J. J., & Alexander, M. S. (2023) · The FASEB Journal · doi:10.1096/fj.202300386rr · Cited by 10
Yoo, A., Ahn, J., Seo, H., Hahm, J., Jung, C. H., Ly, S. Y., & Ha, T. Y. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109532 · Cited by 11
Khouri, H., Roberge, M., Ussher, J. R., & Aguer, C. (2024) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00718.2023 · Cited by 10
Lifestyle Approaches and Glucose Intolerance
Stull, A. J. (2016) · American Journal of Lifestyle Medicine · doi:10.1177/1559827614554186 · Cited by 13
“Skeletal muscle represents the predominant site of insulin resistance in diabetes, and exercising has been shown to improve insulin sensitivity in this tissue.(81,82) The current joint position stand statement from the American College of Sports Medicine and ADA recommends ≥150 min/wk of moderateto vigorous-intensity…”
BackgroundAngiotensin II induces differential insulin action in rat skeletal muscle
Surapongchai, J., Prasannarong, M., Bupha‐Intr, T., & Saengsirisuwan, V. (2017) · Journal of Endocrinology · doi:10.1530/joe-16-0579 · Cited by 9
Tissue Non-Specific Genes and Pathways Associated with Diabetes: An Expression Meta-Analysis
Mei, H., Li, L., Liu, S., Jiang, F., Griswold, M. E., & Mosley, T. H. (2017) · Genes · doi:10.3390/genes8010044 · Cited by 11
A microplate assay for measuring cell death in C2C12 cells
de Lima, T. I., & Silveira, L. R. (2018) · Biochemistry and Cell Biology · doi:10.1139/bcb-2018-0005 · Cited by 9
“Although the etiology of diabetes is multifactorial one of the primary causes of insulin resistance in skeletal muscle cells is the increased production of ROS which is commonly associated with apoptosis and cell death (Barbosa et al. 2013; DeFronzo and Tripathy 2009; Fisher-Wellman and Neufer 2012).”
BackgroundInteractions Between the Neuroendocrine System and T Lymphocytes in Diabetes
Andreone, L., Gimeno, M. L., & Perone, M. J. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00229 · Cited by 11
“Skeletal muscle is the predominant tissue of insulin-mediated glucose uptake in the postprandial state in humans (135); moreover, lipid accumulation in this tissue is associated with insulin resistance.”
BackgroundLow- and high-protein diets do not alter ex vivo insulin action in skeletal muscle
Li, Z., Rasmussen, M. L., Li, J., Henríquez‐Olguín, C., Knudsen, J. R., Søgaard, O. S., Madsen, A. B., & Jensen, T. E. (2018) · Physiological Reports · doi:10.14814/phy2.13798 · Cited by 10
Effect of sub-toxic chlorpyrifos on redox sensitive kinases and insulin signaling in rat L6 myotubes
Shrestha, S., Singh, V. K., Sarkar, S. K., Shanmugasundaram, B., Jeevaratnam, K., & Koner, B. C. (2018) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-018-0379-x · Cited by 10
Lewis, M. T., Kasper, J. D., Bazil, J. N., Frisbee, J. C., & Wiseman, R. W. (2019) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00127.2019 · Cited by 10
Skeletal muscle DNA methylation modifications and psychopharmacologic treatment in bipolar disorder
Burghardt, K. J., Howlett, B. H., Sanders, E., Dass, S. E., Msallaty, Z., Mallisho, A., Seyoum, B., & Yi, Z. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.10.001 · Cited by 10
“Dysfunction in the skeletal muscle’s ability to complete insulin-stimulated glucose uptake is thought to be the primary defect in the development of insulin resistance which is a major component in the development of diabetes (DeFronzo and Tripathy, 2009).”
BackgroundSandoval, C., Askelson, K., Lambo, C. A., Dunlap, K. A., & Satterfield, M. C. (2020) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2020.106556 · Cited by 9
Mechanisms of action of the antidiabetic peptide [S4K]CPF-AM1 in db/db mice
Musale, V., Moffett, R. C., Owolabi, B. O., Conlon, J. M., Flatt, P. R., & Abdel‐Wahab, Y. H. A. (2020) · Journal of Molecular Endocrinology · doi:10.1530/jme-20-0152 · Cited by 10
van Polanen, N., Zacharewicz, E., de Ligt, M., Timmers, S., Moonen‐Kornips, E., Schaart, G., Hoeks, J., Schrauwen, P., & Hesselink, M. K. C. (2021) · Physiological Reports · doi:10.14814/phy2.14692 · Cited by 9
“Compromised insulin-mediated glucose uptake in muscle is commonly observed in middle-aged, overweight individuals and is a hallmark in the pathogenesis of insulin resistance and type 2 diabetes mellitus (T2DM) development (DeFronzo & Tripathy, 2009).”
BackgroundKothmann, K., Jacobsen, V., Laffitte, E., Bromfield, C. R., Grizzaffi, M., Jarboe, M., Braundmeier‐Fleming, A., Bahr, J. M., Nowak, R. A., & Newell‐Fugate, A. E. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00281.2020 · Cited by 12
Wisinski, J. A., Reuter, A., Peter, D. C., Schaid, M. D., Fenske, R. J., & Kimple, M. E. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00051.2021 · Cited by 8
Impaired proteostasis in obese skeletal muscle relates to altered immunoproteasome activity
Fletcher, E., Wiggs, M. P., Greathouse, K. L., Morgan, G. B., & Gordon, P. M. (2022) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2021-0764 · Cited by 11
Activation of inflammatory pathways in PBMCs linking type 2 diabetes in older adults without obesity
Cheng, H.-C., Tsai, S., & Liu, H. (2022) · Experimental Gerontology · doi:10.1016/j.exger.2022.111779 · Cited by 10
Rosen, K. A., Thodge, A., Tang, A., Franz, B. M., Klochko, C. L., & Soliman, S. B. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01107-2 · Cited by 10
“It is known that skeletal muscle insulin resistance is the primary defect in the development of T2DM, often occurring decades before β-cell failure and apparent metabolic dysfunction [60].”
BackgroundResultHe, S., Lu, Y., Zhu, R., Wei, H., Wang, J., Zheng, L. X., & Zhang, Y. (2022) · Life · doi:10.3390/life12081233 · Cited by 9
“Skeletal muscle comprises approximately 40% of the total body weight in humans [1] and is responsible for over 80% of glucose uptake [2].”
BackgroundBiomolecular Mechanisms of Cardiorenal Protection with Sodium-Glucose Co-Transporter 2 Inhibitors
Prandi, F. R., Barone, L., Lecis, D., Belli, M., Sergi, D., Milite, M., Lerakis, S., Romeo, F., & Barillà, F. (2022) · Biomolecules · doi:10.3390/biom12101349 · Cited by 12
Li, C., Li, N., Zhang, Z., Song, Y., Li, J., Wang, Z., Hai, B., & Zhang, Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1127524 · Cited by 14
“In addition, the consumption rate of postprandial blood glucose in skeletal muscle is more than 80%~90% (4).”
BackgroundRole of PPARG (Pro12Ala) in Malaysian type 2 diabetes mellitus patients
Paramasivam, D., Safi, S. Z., Qvist, R., Abidin, I. B. Z., Hairi, N. N., & Chinna, K. (2016) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-015-0462-5 · Cited by 10
“Such IR and IS defects have been shown through several alterations in carbohydrates, lipids, and protein metabolism [7–9].”
BackgroundThakkar, C. S., Kshirsagar, R. R., Naik, V. R., Ghosh, A. R., Vijayakumar, V., Saklani, A., & Kulkarni‐Almeida, A. (2016) · Fitoterapia · doi:10.1016/j.fitote.2016.08.004 · Cited by 9
“Since skeletal muscles comprise of nearly 40 % of the body mass and are responsible for ~80 % of glucose uptake under insulin stimulated conditions [2, 3], impaired skeletal muscle glucose uptake is one of the major causes for the development of Type 2 diabetes mellitus.”
BackgroundHamza, S. M., Sung, M. M. Y., Gao, F., Soltys, C.-L. M., Smith, N. P., MacDonald, P. E., Light, P. E., & Dyck, J. R. B. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.11.029 · Cited by 10
Metadata
- Authors
- DeFronzo, R. A., & Tripathy, D.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Corresponding author
- Tripathy, Devjit
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-11-01
- Volume
- 32
- Issue
- suppl_2
- Pages
- S157-S163
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2811436
- OpenAlex
- W2170869159
- Cited by
- 2,102
- References
- 115
- Citations by year
- 2026: 149 · 2025: 188 · 2024: 187 · 2023: 161 · 2022: 200 · 2021: 199 · 2020: 161 · 2019: 146 · 2018: 166 · 2017: 132 · 2016: 119 · 2015: 99 · 2014: 72 · 2013: 54 · 2012: 29
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- skeletal muscle insulin resistance, type 2 diabetes, insulin resistance, beta-cell failure, type 2 diabetes pathogenesis, glucose tolerance, hyperglycemia
- MeSH terms
- Insulin Secretion, Blood Glucose, Diabetes Mellitus, Type 2, Fatty Acids, Nonesterified, Homeostasis, Humans, Insulin, Insulin Resistance, Glucose Clamp Technique, Muscle, Skeletal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.